Aviva PLC increased its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 5.7% in the 2nd quarter, HoldingsChannel reports. The fund owned 116,447 shares of the technology company’s stock after purchasing an additional 6,297 shares during the quarter. Aviva PLC’s holdings in Veeva Systems were worth $33,534,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Trust Co. of Toledo NA OH purchased a new position in shares of Veeva Systems during the 2nd quarter worth $29,000. Legacy Investment Solutions LLC acquired a new position in Veeva Systems in the second quarter valued at about $32,000. Maseco LLP purchased a new position in Veeva Systems during the second quarter worth about $35,000. Key Financial Inc increased its position in shares of Veeva Systems by 161.0% during the first quarter. Key Financial Inc now owns 154 shares of the technology company’s stock valued at $36,000 after acquiring an additional 95 shares during the last quarter. Finally, Ameritas Advisory Services LLC purchased a new stake in shares of Veeva Systems in the 2nd quarter valued at approximately $68,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Performance
Shares of VEEV opened at $295.23 on Monday. Veeva Systems Inc. has a 1 year low of $201.54 and a 1 year high of $310.50. The stock has a market capitalization of $48.39 billion, a PE ratio of 60.62, a PEG ratio of 2.22 and a beta of 0.98. The stock has a 50-day simple moving average of $286.40 and a 200-day simple moving average of $275.65.
Insider Activity
In other news, insider Eleni Nitsa Zuppas sold 6,000 shares of Veeva Systems stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the sale, the insider directly owned 25,325 shares of the company’s stock, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the transaction, the insider directly owned 23,773 shares in the company, valued at $7,132,850.92. This trade represents a 12.35% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 24,665 shares of company stock worth $7,438,000. 10.30% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on the stock. Wall Street Zen cut shares of Veeva Systems from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings restated a “hold (c+)” rating on shares of Veeva Systems in a research report on Wednesday, October 8th. Needham & Company LLC reiterated a “buy” rating and issued a $355.00 price objective on shares of Veeva Systems in a report on Friday, October 17th. William Blair reissued an “outperform” rating on shares of Veeva Systems in a research note on Friday, October 17th. Finally, Truist Financial lifted their target price on Veeva Systems from $268.00 to $275.00 and gave the company a “hold” rating in a research report on Thursday, August 28th. Seventeen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $307.58.
Check Out Our Latest Research Report on VEEV
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Read More
- Five stocks we like better than Veeva Systems
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- The Most Important Warren Buffett Stock for Investors: His Own
- AI Demand Is Coming—Is Microchip Technology Ready?
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
